perampanel (Fycompa)

From Aaushi
Jump to navigation Jump to search

Introduction

DEA class 3.

Indications

Dosage

  • 8-12 mg (preliminary information, presumably PO QD) (consult package insert)

Adverse effects

Laboratory

Mechanism of action

More general terms

References

  1. FDA News Release, Oct. 22, 2012 FDA approves Fycompa to treat seizures http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm325038.htm
  2. U.S. FDA APPROVES EISAI'S AMPA RECEPTOR ANTAGONIST FYCOMPA<TM> (PERAMPANEL) AS ADJUNCTIVE TREATMENT FOR PARTIAL-ONSET SEIZURES IN PATIENTS WITH EPILEPSY AGE 12 AND OLDER http://www.eisai.com/news/news201274.html
  3. Prescriber's Letter 21(8): 2014 No Detail Document. (subscription needed) http://www.prescribersletter.com